Skip to main content

Animations

MJFF Publications

3341 - 3350 of 9033 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2022
  • 2023
  • 2019
  • 2022
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00473-5
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Childhood Trauma and Parkinson Disease
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000200124
    Citation Count: 8
  • Summary Details
    OPEN
    Title: A progression analysis of motor features in Parkinson's disease based on the mapper algorithm
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1047017
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Temporal order of clinical and biomarker changes in familial frontotemporal dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-022-01942-9
    Citation Count: 131
  • Summary Details
    OPEN
    Title: Novel Green Fluorescent Polyamines to Analyze ATP13A2 and ATP13A3 Activity in the Mammalian Polyamine Transport System
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom13020337
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Motor Complications in Parkinson's Disease: 13‐Year Follow‐up of the CamPaIGN Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27882
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Adaptive and pathological connectivity responses in Parkinson’s disease brain networks
    Journal Name: Cerebral Cortex
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/cercor/bhac110
    Citation Count: 21
  • Summary Details
    OPEN
    Title: PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.3c00555
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulation
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2022.1084782
    Citation Count: 29
  • Summary Details
    OPEN
    Title: AI reveals insights into link between CD33 and cognitive impairment in Alzheimer’s Disease
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1009894
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.